Impact of injection sites for soluble insulin on glycaemic control in type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen

J E HenriksenH Beck-Nielsen


The absorption rate of rapid acting (soluble) insulin is slow from the subcutaneous tissue of the thigh compared to intramuscular injection into the thigh and s.c. injection into the abdominal wall. The aim of the study was to evaluate the impact of soluble insulin injected either intramuscularly into the thigh (IMT), s.c. into the abdominal wall (SCA) or s.c. into the thigh (SCT) on glycaemic control in Type 1 (insulin-dependent) diabetic outpatients treated with the basal bolus insulin delivery regimen. Fifty-five, C-peptide negative Type 1 diabetic outpatients were included in a randomised 3-month intervention study. The insulin doses were adjusted frequently by blinded observers based on the patients' self-monitored blood glucose values and reported hypoglycaemic episodes. The serum fructosamine value was within normal limits in three patients in the IMT group, in six patients in the SCA group and in none of the patients in the SCT group following the intervention period (p < 0.01). However, the difference in mean serum fructosamine values did not reach statistical significance (IMT: 1.24 mmol/l (95% confidence interval; 1.17 to 1.31), SCA: 1.25 mmol/l (1.18 to 1.32), SCT: 1.34 mmol/l (1.26 to 1.41), (p = 0.09). Blood gluco...Continue Reading


May 19, 1979·Lancet·E A Gale, R B Tattersall
Jun 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·J E HenriksenH Beck-Nielsen
May 1, 1990·Diabetic Medicine : a Journal of the British Diabetic Association·A VaagH Beck-Nielsen
Jul 7, 1990·BMJ : British Medical Journal·J Thow, P Home
Dec 1, 1990·Diabetes Care·I B HirschJ S Skyler
Jan 1, 1990·Diabetes Care·A VaagH Beck-Nielsen
Sep 1, 1989·Diabetic Medicine : a Journal of the British Diabetic Association·P I MacfarlaneC S Smith
Oct 1, 1988·Diabetes Care·M SpraulM Berger
Sep 1, 1988·Diabetes Care·I G Lerman, J I Wolfsdorf
Apr 1, 1987·Archives of Disease in Childhood·G Whincup, R D Milner
Mar 1, 1987·Diabetes Care·F J ServiceR A Rizza
Aug 10, 1985·British Medical Journal·S PrammingC Binder
Jan 7, 1983·Clinica Chimica Acta; International Journal of Clinical Chemistry·R N JohnsonJ R Baker

❮ Previous
Next ❯


Oct 12, 2010·Diabetes & Metabolism·A FridUNKNOWN Scientific Advisory Board for the Third Injection Technique Workshop
Jun 1, 1994·Postgraduate Medical Journal·R Taylor, M Vanderpump
Aug 16, 2014·Clinical Drug Investigation·Leszek NosekTim Heise
Nov 19, 2011·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·James Bernasko
Jul 15, 2004·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·R JamalB H Ginsberg
Sep 7, 2016·Mayo Clinic Proceedings·Anders H FridKenneth W Strauss
Sep 7, 2016·Mayo Clinic Proceedings·Anders H FridKenneth W Strauss
Nov 1, 1995·Obesity Research·B Guy-Grand
Mar 16, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Sanjay KalraKenneth W Strauss
Aug 18, 2018·Journal of Diabetes Research·A K J GradelH H F Refsgaard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

© 2022 Meta ULC. All rights reserved